Sandra Silberman

Technik-/Wissenschafts-/F&E-Leiter bei MOLECULIN BIOTECH, INC.

Vermögen: 53 $ am 30.04.2024

69 Jahre

Health Technology

Consumer Services

Aktive Positionen von Sandra Silberman

Unternehmen	Position	Beginn	Ende
MOLECULIN BIOTECH, INC.	Technik-/Wissenschafts-/F&E-Leiter	08.11.2017	-
CNS PHARMACEUTICALS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.12.2017	-

Unternehmen	Position	Beginn	Ende
Eisai Medical Research, Inc.	Corporate Officer/Principal	01.01.2004	-
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2000	-
SCORPIUS HOLDINGS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2013	-

Weill Cornell Medical College	Doctorate Degree
Zanvyl Krieger School of Arts & Sciences	Undergraduate Degree
The Johns Hopkins University School of Medicine	Doctorate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	4
Doctorate Degree	2
Corporate Officer/Principal	1

Sektoral

Health Technology	5
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
SCORPIUS HOLDINGS, INC.	Health Technology
MOLECULIN BIOTECH, INC.	Health Technology
CNS PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.	Health Technology
Eisai Medical Research, Inc.